Searched for
PNEUMOCOCCAL
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 22%
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...23 May, 2026, 10.24 PM IST
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...18 May, 2026, 10.31 PM IST
- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...18 May, 2026, 06.40 PM IST
- Pfizer launches next-gen vaccine for pneumococcal diseasePfizer has introduced its 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India, offering protection against 20 serotypes re...11 Aug, 2025, 08.47 PM IST
- Abbott launches 14-valent pneumococcal vaccine for children in IndiaAbbott India launched PneumoShield 14, a pneumonia vaccine for children aged six weeks and older. This vaccine offers broader protection th...27 Nov, 2024, 05.40 PM IST
- World Vaccination Day: How to register your newborn for free government vaccinesAs the world celebrates World Vaccination Day, India's Universal Immunization Programme (UIP) continues to play a vital role in protecting ...16 Mar, 2023, 02.46 PM IST
- Media report claiming shortage of pneumococcal vaccines 'ill-informed', says Union health ministryThe report, which quoted health officials including Maharashtra's State Immunisation Officer, stated that a tendering delay has led to the ...08 Oct, 2022, 12.42 PM IST
- Indian vaccine makers gaining wider market share in industryAccording to a TOI report, indigenously-manufactured vaccines have started to capture share from MNCs in certain diseases even as the Rs 3,...25 Aug, 2022, 11.41 AM IST
- SII to start supplying 1st made-in-India pneumococcal conjugate vaccine to Centre from WednesdayThe SII has to supply 2.4 crore doses of the vaccine to the Health Ministry by December 2021. It will be sent to 37 consignees all over Ind...06 Apr, 2021, 08.26 PM IST
- Serum Institute launches India's first fully indigenously developed pneumococcal vaccinePNEUMOSIL has been developed through a collaboration spanning over a decade among Serum Institute of India Pvt Ltd, PATH and Bill and Melin...29 Dec, 2020, 11.36 AM IST
- Vardhan launches India's first indigenously developed pneumococcal vaccine 'Pneumosil'During clinical trials, Pneumosil was found to be safe and effective in the prevention of pneumonia and based on which Pneumosil has been l...28 Dec, 2020, 11.42 PM IST
- Serum Institute develops first indigenous vaccine against pneumonia; to be launched next weekIndia's drug regulator in July had granted market approval for the Pneumococcal Polysaccharide Conjugate vaccine, after reviewing the phase...24 Dec, 2020, 10.13 AM IST
- MSF drags govt to Delhi HC over Pfizer's pneumonia vaccine patentThe Indian patent office granted Pfizer a patent for its vaccine PCV13 (13-valent pneumococcal conjugate vaccine), sold here under the bran...14 Oct, 2017, 02.08 AM IST
- India grants Pfizer patent for blockbuster brand Prevenar 13India has seven pneumonia related deaths per 1,000 live births, according to the 2016 Pneumonia and Diarrhea Progress Report.23 Aug, 2017, 08.33 AM IST
- Pfizer's pneumonia vaccine now part of immunization programmeThe company's 13-valent Pneumococcal Conjugate Vaccine (PCV 13) to prevent pneumonia has been selected for immunisation program in certain ...13 May, 2017, 05.57 PM IST
- Lupin to market MSD's pneumonia prevention vaccine in IndiaAs part of the agreement promote and distribute MSD's 23-valent Pneumococcal Polysaccharide Vaccine under a different brand name in the cou...18 Jul, 2013, 01.56 PM IST
- 323 million Indians to be above 65 years by 2050There will be 323 million in India by 2050 in the 65-plus age group as per a report by The Economist Intelligence Unit.05 Oct, 2012, 08.08 PM IST
Load More
